- We will send in 10–14 business days.
/images/books/13225965/9783658165505.jpg)
- Author: Ann-Kathrin Lehnhausen
- Publisher: Springer Gabler
- Year: 2016
- ISBN-10: 3658165502
- ISBN-13: 9783658165505
- Format: 14.8 x 21 x 0.5 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Studies on Competition and Antitrust Issues in the Pharmaceutical Industry (e-book) (used book) | bookbook.eu
Reviews
Description
This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug's patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.16:34:13
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Ann-Kathrin Lehnhausen
- Publisher: Springer Gabler
- Year: 2016
- ISBN-10: 3658165502
- ISBN-13: 9783658165505
- Format: 14.8 x 21 x 0.5 cm, softcover
- Language: English English
This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug's patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.
Reviews